Member Info for Laura2022

Osd

See my previous comments to jaari

Particularly the 2 shocking companies he's promotes (SCE and in Feb TCF)

Continues today

Real spread 1.18p to 1 22

Would imagine Dr G C has added more in the fund raise

Annualised revenues could be £10mln based on below

Current Trading

Order intake for the first quarter of FY26 ended 30 June 2025, including the Contract detailed above, was £2.3 million, an increase of 145% on the same period in the prior year. This strong performance is in line with the Board's expectations for the quarter

Fully funded

Sold at 1.60+ last week bought back today and yesterday

Https://www.bbc.co.uk/news/resources/idt-66cdf862-5e96-4e6e-90b8-a407b597c8d9

"Professional fees"

To whom and for what??????

Nice 1mln buy

Seller out

Have been watching GENF for months as you can see from previous posts

10mln buy ?

Was a patient ride from 13p

Good luck everyone

At it again

William

Aka TommyD25 aka Santa2024 aka Mainman25

No thanks

Very clearly explained frontera

Thanks

Companies often do this when they see imminent and sustained improvements

The Company is also reviewing incentives to executive directors and other senior personnel, with a view to making further SARs awards in due course. Such SARs are expected to be on broadly similar term

Meanwhile PYC have won almost their own market capitalisation in contracted revenues over the last 12mths and are a fair wind away from breakeven

Meanwhile SCE have lost £5mln -10mln every year for the last 5yrs

Please go elsewhere Jaari888

Yes, I agree. The 5 yr P and L accounts on SCE and PCF ( formerly EVG) are appalling

As a financial advisor i find this worrying Dr Jan

"was surprised about the deep fall afterwards)."

It literally was a horror show of a financial out look

Burt

This person (Jaari888) has had a 15mth infatuation with PYC

Jaari

You haven't posted on SCE sinc this

Going Concern and Material Uncertainty Statement

The continued operation of the Company as a going concern is dependent on its ability to successfully navigate the current scale-up phase, where the efficiency of the production process will determine the sales volume achievement, since demand is running well ahead of capacity. The Directors have identified two key areas of material uncertainty that may cast significant doubt over the Company's ability to continue as a going concern: cost and yield challenges and flexibility in commercial arrangements and level of committed funding.